Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Circulation 111:343349
Umbricht D, Schmid L et al (2000)
10.1074/jbc.M115.679514 J
Looking to the next generation of obesity treatments, combinations of GLP-1 with other entero-pancreatic hormones with complementary actions and/or synergistic potential (such as glucose-dependent insulinotropic polypeptide (GIP), glucagon, and amylin) are under investigation to enhance the WL and cardiometabolic benefits of GLP-1 RA
Als Financieel Medewerker ben je verantwoordelijk voor diverse financile taken binnen onze organisatie
US$ 22.03
US$ 25.54
US$ 24.87
US$ 22.15
